Mr. Speaker, macular degeneration is the leading cause of vision loss for Canadian seniors. It affects thousands of people.
The government agency in charge of evaluating drug costs is recommending a drug that costs seniors a staggering $1,500 a month instead of a drug which costs only $7 a month. Experts say these drugs are virtually identical.
Why is the government choosing to drain seniors' pocketbooks?